USpolicy

News

ACIP pushes back vote on hepatitis B vaccine

ACIP has agreed to push back a vote on recommendations for a birth dose of hepatitis B vaccine, as panellists were unhappy with the proposed wording.

News

ACIP consider the MMRV around a horseshoe table

ACIP votes against first-dose MMRV for under 4s

ACIP votes down recommendation allowing MSD's MMRV shot as an option for children under four, but there's confusion about the coverage implications.

Market Access

pharmaphorum podcast Episode 141, Alice Valder Curran

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

Alice Valder Curran, a partner at Hogan Lovells, provides an update on what's happening right now with Most Favoured Nations drug pricing.

News

Dr Susan Monarez in front of the Senate HELP Committee

Monarez: Kennedy has plan to change child vaccine schedule

Fired CDC chief Susan Monarez told the Senate HELP committee today that HHS Secretary Kennedy has a plan to change to child vaccinations this month.

News

Flood of warning letters follows DTC ad clampdown

The FDA has lost no time following through on its plan to tighten up DTC advertising of medicines, sending out dozens of untitled and warning letters.

News

FDA's Makary explains 'overdue' pharma ads crackdown

FDA Commissioner Marty Makary has called DTC ads for medicines a "public health crisis" as the industry prepares for a regulatory crackdown.

ACIP pushes back vote on hepatitis B vaccine

ACIP votes against first-dose MMRV for under 4s

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

Monarez: Kennedy has plan to change child vaccine schedule

Flood of warning letters follows DTC ad clampdown

FDA's Makary explains 'overdue' pharma ads crackdown

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

USpolicy

Editor's Picks